NIH-funded research NIH-funded research

Creating new drug-like molecules with increased rigidity

Official title: Development and Applications of Reactions to Enable Molecular Rigidification

Funded at Univ of North Carolina Chapel Hill · NIH-11135518 · Data updated 2026-11-12

This study is exploring new ways to make stronger molecules that could lead to better antifungal medicines, helping patients who need effective treatments for fungal infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJuly 15, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$371,371
NIH project number5R35GM155260-02
Project IDNIH-11135518 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from fungal infections who may benefit from new antifungal treatments.

Less likely to help

Patients with non-fungal infections or those not responding to antifungal treatments may not benefit from this research.

What this research studies

This research focuses on developing new chemical reactions that enhance the rigidity of molecules, which is crucial for their effectiveness as drugs. By using innovative methods involving sulfone anions and palladium catalysis, the team aims to create small and medium-sized strained rings that can lead to the synthesis of complex natural products with antifungal properties. The approach also includes stabilizing highly reactive components to improve drug development. Patients may benefit from new antifungal agents that arise from these advancements.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective antifungal medications.

How similar studies have gone: Other research has shown promise in using similar chemical approaches to develop effective drug candidates, indicating potential for success in this area.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Wilkerson-Hill, Sidney Malik — Univ of North Carolina Chapel Hill
  • Study coordinator: Wilkerson-Hill, Sidney Malik

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.